Looking for volunteers
Safety of Minimally Invasive Surgery Using Endoscopic Stapler in Early Stage Cervical Cancer Patients (SOLUTION)
NCT04370496 · Seoul National University Hospital · Updated 26 June 2023
- What is being tested
- Minimally invasive surgery using endoscopic stapler
- For
- Cervical Cancer; Cervical Cancer Stage IB1; Minimally Invasive Surgery
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years and older. About 124 people. The full rules are on the registry page.
- Where
- South Korea (3 sites)
- When
- Starts or started 2 July 2020, ends 31 Dec 2028. Registered 1 May 2020.
- Results
- None posted yet.
In the researchers' words
The SOLUTION trial aims to show the efficacy and safety of performing radical hysterectomy by minimally invasive surgery using an endoscopic stapler in patients with cervical cancer stage IB1 (FIGO staging 2009) and thus to prove that minimally invasive surgery is non-inferior to open surgery.
Sites
- Seoul National University HospitalSeoul, South Korea
- Samsung Medical Center, Sungkyunkwan University School of MedicineSeoul, South Korea
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ajou University School of MedicineSuwon, South Korea